STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2911 by analyst upside · 2026-08-13
FTRE
Fortrea Holdings Inc.
Healthcare · Market Cap $2B · P/E 0x
ANALYST PRICE TARGET
+12.1%
implied upside to consensus target
Current Price $18.33
Consensus Target $20.55
Bull Target $26.0
Bear Target $13.0
Analysts Covering 11
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
5
Hold
5
Sell
1
52-Week Low $7.1
52-Week High $21.39
YTD Return +9.0%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) N/A
Forward P/E 16.1x
EPS (TTM) $-0.83
PEG Ratio 0.34
Dividend Yield N/A
Revenue (TTM) $2.7B
Profit Margin -3.2%
52-WEEK RANGE
52-Week Low $7.1
52-Week High $21.39
Current Price $18.33
Bear Target $13.0
Bull Target $26.0
● Now $18.33 ● Target $20.55
TRADING DATA
Avg Volume 1.4M
YTD Return +9.0%
Analyst Count 11
Consensus Hold
Upside to Target +12.1%
Last Updated 2026-08-13

ANALYST SUMMARY

Fortrea Holdings Inc. (FTRE) is currently trading at $18.33 with a Wall Street consensus price target of $20.55, implying potential upside of 12.1% over the next 12 months. 11 analysts currently cover FTRE, with a consensus rating of Hold - 45% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $26.0, while the most cautious has a target of $13.0.

FTRE operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 9.0% year-to-date and is currently trading near the upper end of its 52-week range of $7.1 – $21.39.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for FTRE, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Mizuho - Reiterated
Neutral → Neutral 2026-05-12 Building track record
Citigroup - Reiterated
Buy → Buy 2026-05-06 Building track record
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-05-06 Building track record
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-04-14 Building track record
Evercore ISI Group - Reiterated
Outperform → Outperform 2026-04-08 Building track record
TD Cowen ↑ Upgrade
Hold → Buy 2026-03-09 Building track record
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-02-27 Building track record
Baird - Reiterated
Outperform → Outperform 2026-02-27 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
42
out of 100
Coverage depth
19/30
Consensus clarity
16/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →